Co-infection with Pansensitive and Multidrug-Resistant Strains of Mycobacterium tuberculosis

Emerging Infectious Diseases

Volumn 15, Issue 4, 2009, Pages 578-580

  Mendez, Michael P ^a,d   Landon, Mary E ^b   McCloud, Mary K ^b   Davidson, Peter ^c   Christensen, Paul J ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b Washtenaw County Public Health Department   (United States)

^c Department of Community Health ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE REPORT; CONTACT EXAMINATION; COUGHING; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY TEST; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; PATIENT CARE; PNEUMONIA; SOMALIA; SPUTUM EXAMINATION; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

COMMUNICABLE DISEASES, EMERGING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EMIGRATION AND IMMIGRATION; GENOTYPE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; SOMALIA; TUBERCULOSIS, PULMONARY; UNITED STATES; YOUNG ADULT;

EID: 65349155900     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1504.080592     Document Type: Article

References (15)

1. Bilaceroǧlu S, Perim K, Büyüksirin M, Celikten E. Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial. Int J Tuberc Lung Dis. 1999;3:47-54.
2. Smego RA, Ahmed N. A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:208-13.
3. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev. 2006;19:658-85. DOI: 10.1128/CMR.00061-05
4. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med. 2003;349:1149-56. DOI: 10.1056/NEJMra021964
5. Centers for Disease Control and Prevention. National Genotyp-ing Service Division of Tuberculosis Elimination [cited 2009 Feb 18]. Available from http://www.cdc.gov/tb/pubs/tbfactsheets/ genotyping.htm
6. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:2869-73. DOI: 10.1073/pnas.0511240103
7. Centers for Disease Control and Prevention. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1-77.
8. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341:1174-9. DOI: 10.1056/NEJM199910143411602
9. Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2002;35:146-55. DOI: 10.1086/340980
10. Chaves F, Dronda F, Alonso-Sanz M, Noriega AR. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS. 1999;13:615-20. DOI: 10.1097/00002030-199904010-00011
11. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afon-so O, Martin C, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 2001;163:717-20.
12. Garcia SN, Pillus L. A unique class of conditional sir2 mutants displays distinct silencing defects in Saccharomyces cerevisiae. Genetics. 2002;162:721-36.
13. Horn DL, Hewlett D Jr, Haas WH, Butler WR, Alfalla C, Tan E, et al. Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting. Ann Intern Med. 1994;121:115-6.
14. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, God-frey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358:1687-93. DOI: 10.1016/S0140-6736(01)06712-5
15. Braden CR, Morlock GP, Woodley CL, Johnson KR, Colombel AC, Cave MD, et al. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis. 2001;33:e42-7. DOI: 10.1086/322635